GS1-11 sacitizumab govitecan (SG) vs treatment of physician’s choice (TPC): Efficacy by trop-2 expression in the TROPiCS-02 study of patients (pts) with HR+/HER2- metastatic breast cancer (mBC)
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.